Clinical Trials Directory

Trials / Completed

CompletedNCT01171365

Small Particle Steroids in Refractory Asthma

Small Particle Inhaled Steroids in Refractory Steroid-responsive Asthma

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Nottingham · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether an inhaled steroid with a small particle size can be an additional treatment option in patients with refractory eosinophilic asthma.

Detailed description

We have identified a group of patients with refractory asthma who have ongoing eosinophilic airway inflammation despite high dose inhaled corticosteroids. Traditional inhaled steroids have a relatively proximal airway distribution which may lead to inadequate treatment of the distal airways. We aim to demonstrate that a steroid inhaler with a smaller particle size which targets the distal airways can be a useful additional treatment option in this group of patients.

Conditions

Interventions

TypeNameDescription
DRUGCiclesonideInhaled ciclesonide 320mcg twice daily
DRUGPlaceboMatched placebo inhaler two inhalations twice daily

Timeline

Start date
2010-01-01
Primary completion
2013-10-01
Completion
2013-12-01
First posted
2010-07-28
Last updated
2014-01-31

Locations

2 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01171365. Inclusion in this directory is not an endorsement.